Introduction {#s1}
============

Pre-implantation development of mammalian embryos encompasses a series of critical dynamic events, such as the transition from a single-cell zygote to a multicellular blastocyst and the first segregation of cells within the embryo with the formation of the inner cell mass (ICM) surrounded by trophectoderm (TE) cells. ICM retains pluripotency and gives rise to the embryo proper, whereas TE cells play an important role in embryonic implantation in the uterine endometrium and placental formation. In humans, the embryonic genome activation (EGA) program is functional by day 3 after fertilization [@pone.0039306-Dobson1]. The 6--8 cell stage embryo (day 3 post-fertilization) starts the process of "compaction" that leads to the generation of the tightly organized cell mass of the morula and is followed by differentiation of the morula into a blastocyst [@pone.0039306-Niakan1]. The transition from day 3 embryos to day 5 blastocysts is likely to be controlled by many and specific changes in the expression of different genes as this process involves both cellular differentiation and transcriptional reprogramming. Although some genes that are specifically expressed in day 3 human embryos and in TE cells, such as *CCNA1* and *GATA3* respectively have been identified [@pone.0039306-Galan1], [@pone.0039306-Home1], our knowledge on the changes in gene expression associated with the initial embryo-TE transition and the specification of the TE cell lineage is still limited. In addition, since TE biopsies from day 5 human blastocysts might become a reliable alternative to blastomere biopsies to assess the expression of biomarkers of embryo viability [@pone.0039306-Jones1], a better knowledge of the genes that are specifically expressed in TE cells and the embryo proper is crucial. Recent technological advances in mRNA amplification methods and DNA microarray assays have allowed the simultaneous analysis of the transcript level of thousands of genes in one experiment, thus offering a global view of the molecular events regulating physiological functions and cellular processes [@pone.0039306-Shalon1], [@pone.0039306-Assou1]. Indeed, these methodologies have already contributed to improving our knowledge on the genetic network controlling key stages of pre-implantation embryo development [@pone.0039306-Assou2], [@pone.0039306-Assou3], [@pone.0039306-Hamatani1], [@pone.0039306-Zhang1]. In this study, we used high-density oligonucleotide Affymetrix HG-U133P microarray chips to analyze the gene transcription profiles of single day 3 human embryos and TE cells isolated from day 5 blastocysts. By comparing the transcriptomes of TE cells and day 3 embryos, we identified the specific molecular signature of human TE cells. These findings should provide a base for investigating the molecular mechanisms of the embryo-TE transition as well as important insights for the development of diagnostic tests to test blastocyst quality in assisted reproduction programs.

Results {#s2}
=======

Dynamic Changes in Overall Gene Expression in Mature MII Oocytes, Single Day 3 Embryos, TE Cells from Day 5 Blastocysts and hESCs {#s2a}
---------------------------------------------------------------------------------------------------------------------------------

In order to determine the global gene expression variation in the different samples, we established the gene expression profile of mature MII oocytes (n = 3), day 3 single embryos (n = 6), TE samples from day 5 blastocysts (n = 5) and hESCs (n = 4) (to represent the ICM) by using high-density oligonucleotide Affymetrix HG-U133P microarray chips. A non-supervised analysis using the principal components analysis (PCA) showed that samples from the same group clustered together very tightly ([Figure 1A](#pone-0039306-g001){ref-type="fig"}), corroborating the robustness of the Affymetrix microarrays [@pone.0039306-Irizarry1]. Moreover, a non-supervised hierarchical clustering analysis of the array data (based on 15,000 genes) clustered perfectly the different samples, confirming their very specific expression profiles ([Figure 1B](#pone-0039306-g001){ref-type="fig"}). Finally, a scatter plot analysis ([Figure S1](#pone.0039306.s001){ref-type="supplementary-material"}) showed that expression variations between mature MII oocytes and single day 3 embryos were high as illustrated by the dispersed scatter plots and the low correlation coefficient (0.51). Conversely, the differences in gene expression between day 3 embryos and TE or hESC samples were lower as indicated by the tighter scatter plots and the high correlation coefficients (0.60--0.76) ([Figure S1](#pone.0039306.s001){ref-type="supplementary-material"}). These results reveal dynamic transcriptome changes during the transition from mature oocyte to day 3 embryo and from day 3 embryo to blastocyst. These "dynamic patterns" are due to the large-scale degradation of human maternal transcripts and the activation of embryonic genes, as was also observed in the mouse [@pone.0039306-Hamatani1], [@pone.0039306-Wang1].

![Gene expression patterns of day 3 human embryos, mature MII oocytes, TE cells and hESC cells.\
(A) PCA two-dimensional scatter plots represent the differential gene expression patterns of the different human samples. Each dot represents a sample and the color its origin: oocytes (green dots), day 3 embryos (blue dots), TE from day 5 embryos (black dots) and hESCs (red dots). Samples can be divided in four distinct areas based on their gene expression. (B) Average-link hierarchical clustering of 15,000 genes delineated four major gene clusters: (a) genes specifically detected in mature MII oocytes; (b) genes over-expressed in hESCs; (c) genes up-regulated in TE and (d) genes specifically over-expressed in day 3 embryos.](pone.0039306.g001){#pone-0039306-g001}

Comparison of the Gene Expression Profiles of Day 3 Embryos and TE Cells Isolated from Day 5 Blastocysts {#s2b}
--------------------------------------------------------------------------------------------------------

We then compared the expression profiles of day 3 embryos and TE cells, by using the significance analysis of microarrays (SAM) software with a 2-fold change cut-off and false discovery rate (FDR) \<1%. We found that 2,196 transcripts were up-regulated in human TE cells ("TE molecular signature") and 1,714 in day 3 embryos ("day 3 embryo molecular signature") ([Figure 2](#pone-0039306-g002){ref-type="fig"}). The comprehensive lists of these signatures are presented in [Tables S1](#pone.0039306.s006){ref-type="supplementary-material"} and [S2](#pone.0039306.s007){ref-type="supplementary-material"} and the 100 genes with the highest fold change and significant statistical value (FDR = 0) for each signature are listed in [Table 1](#pone-0039306-t001){ref-type="table"} and [2](#pone-0039306-t002){ref-type="table"}. The "day 3 embryo molecular signature" included the Developmental Pluripotency Associated gene 5 (*DPPA5)*, members of the Ret finger protein-like gene family (*RFPL1, 2* and *3*), of the NLR family (*NALP4*, *5*, *9*, *11* and *13*), and of the melanoma antigen family (*MAGEA1*, *2*, *3*, *5*, *6* and *12*). Several maternal genes were found in this signature, such as members of the Zona Pellucida gene family (*ZP2*, *3* and *4*), *ZAR1*, *AURKC* and *FIGLA*, suggesting that they are still active in day 3 embryos. Several transcription factors were also significantly over-expressed in day 3 embryos, such as *TFB1M* and *TFB2M*, the transcriptional regulators *MBD3L2* and *ZSCAN4*, as well as metabolic genes such as Pyruvate Dehydrogenase Kinase 3 (*PDK3*) and Lactate Dehydrogenases (*LDHC*). The "TE molecular signature" comprised genes important for placental development (*PGF* and *TFAP2A*), cytoskeleton-associated genes (*Keratin 18* and *19*), and genes encoding S100 calcium binding proteins (*S100P*, *S100A6*, *10*, *13*, *14* and *16*), retinoid receptor-related testis-associated receptors (*NR2F2* and *NR2F6*) or the B receptor (*CCKBR*). Moreover, genes encoding extracellular matrix proteins, such as Laminins (*LAMA1*, *LAMA5* and *LAMC1*) and Integrins (*ITGB4* and *ITGB5*) were also up-regulated. Gene ontology (GO) annotations were used to explore the specific functional properties of the two molecular signatures ([Figure 3](#pone-0039306-g003){ref-type="fig"}). The day 3 embryo molecular signature was enriched in genes associated with localization in the "nucleus", while genes associated with the "cytoplasm" localization were over-represented in the TE molecular signature. Concerning the "biological processes", the day 3 embryo molecular signature was enriched in genes involved in the regulation of cellular processes, transcription and post-translational protein modifications. Conversely, in the TE molecular signature, genes connected with different metabolic and steroid biosynthetic processes were over-represented. The "molecular function" analysis showed that genes involved in oxido-reductase activity were significantly enriched in the TE signature (*p*\<0.001), whereas genes related to "GTPase activity" and DNA binding were over-represented in the day 3 embryo signature. Finally, the expression pattern of 11 genes belonging to the TE (*GATA3*, *LAMA1*, *KRT18, HSD3B1*, *HSD17B1* and *DNMT3L*) or to the day 3 embryo molecular signature (*MBD3L2*, *CCNA1*, *BIK*, *RFPL2* and *FIGLA*) was confirmed by qRT-PCR analysis using specific primer pairs ([Table S3](#pone.0039306.s008){ref-type="supplementary-material"}). All qRT-PCR data were normalized to *GAPDH* to control for variations in mRNA recovery and RT efficiency ([Figure S2](#pone.0039306.s002){ref-type="supplementary-material"}).

![Day 3 embryo and TE molecular signatures:\
Heat map of the molecular signatures in six day 3 embryos and five TE samples. Each horizontal line represents a gene and each column represents a single sample. The color intensity indicates the level of gene expression (red for up-regulation and blue for down-regulation) "see also [Table S1](#pone.0039306.s006){ref-type="supplementary-material"} and [S2](#pone.0039306.s007){ref-type="supplementary-material"}".](pone.0039306.g002){#pone-0039306-g002}

![Gene Ontology (GO) annotations of the day 3 embryo and TE molecular signatures.\
We compared the GO annotations of genes specifically over-expressed in day 3 embryos and in TE cells by using the Babelomics web tool (<http://babelomics.bioinfo.cipf.es/>). Histograms show the percentage of genes with a specific GO annotation in day 3 embryos (white) or in TE samples (black). Only GO categories which differed significantly (*p* value \<0.01) between the two groups are shown.](pone.0039306.g003){#pone-0039306-g003}
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###### List of the 100 genes with the highest fold change in day 3 human embryos in comparison to TE samples.

![](pone.0039306.t001){#pone-0039306-t001-1}

  Probesets        Gene Name                                      Gene Title                                        UniGene    ChromosomalLocation   Fold change   FDR (%)
  --------------- ----------- ----------------------------------------------------------------------------------- ----------- --------------------- ------------- ---------
  1552531_a\_at     NALP11                          NLR family, pyrin domain containing 11                         Hs.375039       chr19q13.42          1893          0
  242334_at          NALP4                           NLR family, pyrin domain containing 4                         Hs.631533       chr19q13.42           892          0
  214957_at          ACTL8                                       actin-like 8                                       Hs.2149       chr1p36.2-p35          755          0
  1556096_s\_at     UNC13C                                     unc-13 homolog C                                    Hs.443456       chr15q21.3            663          0
  207443_at          NR2E1                      nuclear receptor subfamily 2, group E, member 1                    Hs.157688         chr6q21             625          0
  1553619_a\_at     TRIM43                              tripartite motif-containing 43                             Hs.589730        chr2q11.1            519          0
  1552405_at         NALP5                           NLR family, pyrin domain containing 5                         Hs.356872       chr19q13.42           448          0
  209160_at         AKR1C3                          aldo-keto reductase family 1, member C3                        Hs.78183       chr10p15-p14           431          0
  1552456_a\_at     MBD3L2                        methyl-CpG binding domain protein 3-like 2                       Hs.567667       chr19p13.2            394          0
  1557085_at        TMEM122                                placenta-specific 1-like                                Hs.132310       chr11q12.1            387          0
  39318_at           TCL1A                                T-cell leukemia/lymphoma 1A                               Hs.2484        chr14q32.1            342          0
  234393_at          HDAC9                                   histone deacetylase 9                                 Hs.196054        chr7p21.1            315          0
  1552912_a\_at      IL23R                                  interleukin 23 receptor                                Hs.200929        chr1p31.3            306          0
  1552852_a\_at     ZSCAN4                         zinc finger and SCAN domain containing 4                        Hs.469663       chr19q13.43           282          0
  226117_at          TIFA                 TRAF-interacting protein with a forkhead-associated domain               Hs.310640         chr4q25             275          0
  222361_at        LOC643224                              similar to tubulin, beta 8                               Hs.551805        chr9q34.3            273          0
  229105_at          GPR39                               G protein-coupled receptor 39                             Hs.432395       chr2q21-q22           255          0
  225626_at          PAG1               phosphoprotein associated with glycosphingolipid microdomains 1            Hs.266175       chr8q21.13            230          0
  1557544_at       C10orf80                           chromosome 10 open reading frame 80                          Hs.253576       chr10q25.1            209          0
  210634_at         KLHL20                                kelch-like 20 (Drosophila)                               Hs.495035     chr1q24.1-q24.3         206          0
  206343_s\_at       NRG1                                        neuregulin 1                                      Hs.453951       chr8p21-p12           184          0
  207213_s\_at       USP2                               ubiquitin specific peptidase 2                             Hs.524085       chr11q23.3            182          0
  1563120_at       Hs.623820                        Homo sapiens, clone IMAGE:5528155, mRNA                        Hs.630724                             175          0
  237131_at        LOC645469                             hypothetical protein FLJ36032                             Hs.297967        chr1q21.3            172          0
  221630_s\_at       DDX4                          DEAD (Asp-Glu-Ala-Asp) box polypeptide 4                        Hs.223581     chr5p15.2-p13.1         171          0
  241550_at          DPPA5                          developmental pluripotency associated 5                        Hs.125331         chr6q13             167          0
  217365_at         PRAMEF5                            similar to PRAME family member 6                                            chr1p36.21            157          0
  1570337_at         FIGLA                     folliculogenesis specific basic helix-loop-helix                    Hs.407636        chr2p13.3            157          0
  206140_at          LHX2                                       LIM homeobox 2                                     Hs.445265      chr9q33-q34.1          154          0
  229738_at         DNAH10                             dynein, axonemal, heavy chain 10                            Hs.622654       chr12q24.31           154          0
  209785_s\_at      PLA2G4C              phospholipase A2, group IVC (cytosolic, calcium-independent)              Hs.631562       chr19q13.3            149          0
  237613_at          FOXR1                                      forkhead box R1                                    Hs.116679       chr11q23.3            147          0
  236914_at        AW080028                                                                                                                              137          0
  210467_x\_at      MAGEA12                              melanoma antigen family A, 12                                               chrXq28             137          0
  242128_at          OTX2                            orthodenticle homolog 2 (Drosophila)                          Hs.288655      chr14q21-q22           128          0
  220535_at         FAM90A1                      family with sequence similarity 90, member A1                     Hs.196086       chr12p13.31           128          0
  215048_at          SUHW2                      suppressor of hairy wing homolog 2 (Drosophila)                    Hs.43834        chr22q11.22           127          0
  207934_at          RFPL1                                 ret finger protein-like 1                               Hs.648249       chr22q12.2            127          0
  209994_s\_at       ABCB1                  ATP-binding cassette, sub-family B (MDR/TAP), member 1                 Hs.489033        chr7q21.1            125          0
  207227_x\_at       RFPL2                                 ret finger protein-like 2                               Hs.157427       chr22q12.3            116          0
  238218_at        LOC648473                            hypothetical protein LOC648473                                                                   112          0
  214603_at         MAGEA2                               melanoma antigen family A, 2                              Hs.169246         chrXq28             111          0
  217590_s\_at       TRPA1            transient receptor potential cation channel, subfamily A, member 1           Hs.137674         chr8q13             110          0
  208312_s\_at      PRAMEF1                                  PRAME family member 1                                 Hs.104991       chr1p36.21            109          0
  223866_at          ARMC2                               armadillo repeat containing 2                                               chr6q21             106          0
  216001_at        LOC390999                                PRAME family member 12                                 Hs.156406       chr1p36.21            106          0
  213228_at          PDE8B                                   phosphodiesterase 8B                                  Hs.584830        chr5q14.1            104          0
  1552807_a\_at    SIGLEC10                          sialic acid binding Ig-like lectin 10                         Hs.284813       chr19q13.3            104          0
  236205_at        Hs.13188                 similar to ATP-binding cassette, sub-family C, member 6                Hs.13188        chr16p12.3            104          0
  209942_x\_at      MAGEA3                               melanoma antigen family A, 3                              Hs.417816         chrXq28             100          0
  226271_at          GDAP1                 ganglioside-induced differentiation-associated protein 1                Hs.168950       chr8q21.11            98           0
  240031_at        AA994467                           Baculoviral IAP repeat-containing 2                          Hs.503704        chr11q22             98           0
  209570_s\_at      D4S234E               DNA segment on chromosome 4 (unique) 234 expressed sequence              Hs.518595        chr4p16.3            98           0
  206207_at           CLC                               Charcot-Leyden crystal protein                              Hs.889         chr19q13.1            96           0
  230626_at         TSPAN12                                     tetraspanin 12                                     Hs.16529        chr7q31.31            93           0
  216034_at          SUHW1                      suppressor of hairy wing homolog 1 (Drosophila)                    Hs.178665       chr22q11.22           89           0
  231756_at           ZP4                                zona pellucida glycoprotein 4                             Hs.136241         chr1q43             89           0
  202388_at          RGS2                         regulator of G-protein signalling 2, 24 kDa                      Hs.78944          chr1q31             85           0
  205747_at          CBLN1                                  cerebellin 1 precursor                                 Hs.458423       chr16q12.1            84           0
  230753_at        LOC197135                                hypothetical LOC197135                                 Hs.11594        chr15q21.1            83           0
  236117_at        Hs.42747                                    Transcribed locus                                   Hs.42747                              83           0
  1556834_at       Hs.562766                               CDNA clone IMAGE:5296106                                Hs.562766                             83           0
  209278_s\_at       TFPI2                             tissue factor pathway inhibitor 2                           Hs.438231         chr7q22             81           0
  240318_at          AFMID                                      Arylformamidase                                    Hs.558614       chr17q25.3            80           0
  1557257_at         BCL10                                  B-cell CLL/lymphoma 10                                 Hs.193516         chr1p22             80           0
  236504_x\_at      C6orf52                           chromosome 6 open reading frame 52                           Hs.61389         chr6p24.1            80           0
  204438_at          MRC1                                 mannose receptor, C type 1                               Hs.75182        chr10p12.33           80           0
  1559108_at         VPS53                        Vacuolar protein sorting 53 (S. cerevisiae)                      Hs.461819       chr17p13.3            79           0
  210180_s\_at      SFRS10       splicing factor, arginine/serine-rich 10 (transformer 2 homolog, Drosophila)      Hs.533122      chr3q26.2-q27          77           0
  214960_at          API5                                    apoptosis inhibitor 5                                 Hs.435771      chr11p12-q12           77           0
  232692_at          TDRD6                                 tudor domain containing 6                               Hs.40510         chr6p12.3            76           0
  240731_at        LOC441316                                                                                                                             76           0
  230697_at          BBS5                                   Bardet-Biedl syndrome 5                                Hs.233398        chr2q31.1            75           0
  244206_at         ANUBL1                       AN1, ubiquitin-like, homolog (Xenopus laevis)                     Hs.89029        chr10q11.21           75           0
  222921_s\_at       HEY2                      hairy/enhancer-of-split related with YRPW motif 2                   Hs.144287         chr6q21             74           0
  1557146_a\_at    FLJ32252                              hypothetical protein FLJ32252                             Hs.250557       chr16p13.3            73           0
  241382_at         PCP4L1                              Purkinje cell protein 4 like 1                             Hs.433150        chr1q23.3            73           0
  226811_at         FAM46C                       family with sequence similarity 46, member C                      Hs.356216         chr1p12             73           0
  44783_s\_at        HEY1                      hairy/enhancer-of-split related with YRPW motif 1                   Hs.234434         chr8q21             73           0
  239061_at          TPRXL                            tetra-peptide repeat homeobox-like                           Hs.638296        chr3p25.1            72           0
  223562_at          PARVG                                       parvin, gamma                                     Hs.565777     chr22q13.2-q13          69           0
  219352_at          HERC6                                   hect domain and RLD 6                                 Hs.529317        chr4q22.1            69           0
  1553697_at        C1orf96                           chromosome 1 open reading frame 96                           Hs.585011       chr1q42.13            68           0
  1568924_a\_at    FLJ35834                              hypothetical protein FLJ35834                             Hs.159650       chr7q31.32            68           0
  221314_at          GDF9                               growth differentiation factor 9                            Hs.25022         chr5q31.1            67           0
  228737_at        C20orf100                         chromosome 20 open reading frame 100                          Hs.26608        chr20q13.12           66           0
  240070_at          VSIG9                       V-set and immunoglobulin domain containing 9                      Hs.421750       chr3q13.31            66           0
  231448_at          Tenr                             testis nuclear RNA-binding protein                           Hs.518957         chr4q27             65           0
  214612_x\_at      MAGEA6                               melanoma antigen family A, 6                              Hs.441113         chrXq28             64           0
  206696_at         GPR143                              G protein-coupled receptor 143                             Hs.74124         chrXp22.3            62           0
  205551_at          SV2B                              synaptic vesicle glycoprotein 2B                            Hs.592018       chr15q26.1            61           0
  219686_at         STK32B                                serine/threonine kinase 32B                              Hs.133062     chr4p16.2-p16.1         61           0
  230645_at          FRMD3                                 FERM domain containing 3                                Hs.127535       chr9q21.32            60           0
  1555396_s\_at    LOC340602                                 similar to CG32656-PA                                 Hs.97053        chrXp11.22            59           0
  237464_at          IMAA                                      SLC7A5 pseudogene                                   Hs.448808       chr16p12.2            58           0
  212158_at          SDC2      syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated, fibroglycan)    Hs.1501        chr8q22-q23           57           0
  220657_at         KLHL11                                kelch-like 11 (Drosophila)                               Hs.592134       chr17q21.2            57           0
  223883_s\_at       STK31                                serine/threonine kinase 31                               Hs.309767        chr7p15.3            57           0
  222925_at          DCDC2                             doublecortin domain containing 2                            Hs.61345         chr6p22.1            56           0
  210148_at        AF305239                        homeodomain interacting protein kinase 3                        Hs.201918        chr11p13             56           0

10.1371/journal.pone.0039306.t002

###### List of the 100 genes with the highest fold change in TE samples in comparison to day 3 embryos.
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  Probesets        Gene Name                                     Gene Title                                       UniGene    Chromosomal Location   Fold Change   FDR (%)
  --------------- ----------- --------------------------------------------------------------------------------- ----------- ---------------------- ------------- ---------
  205980_s\_at      ARHGAP8                  Rho GTPase activating protein 8/PRR5-ARHGAP8 fusion                                 chr22q13.31            514          0
  218237_s\_at      SLC38A1                          solute carrier family 38, member 1                          Hs.533770       chr12q13.11            469          0
  201596_x\_at       KRT18                                       keratin 18                                      Hs.406013         chr12q13             445          0
  204515_at         HSD3B1      hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1     Hs.364941        chr1p13.1             383          0
  227048_at          LAMA1                                    laminin, alpha 1                                   Hs.270364       chr18p11.31            372          0
  34260_at         KIAA0683                 TEL2, telomere maintenance 2, homolog (S. cerevisiae)                Hs.271044        chr16p13.3            361          0
  224348_s\_at     AF116709                                                                                                                             341          0
  223168_at          RHOU                             ras homolog gene family, member U                          Hs.647774     chr1q42.11-q42.3         310          0
  204158_s\_at      TCIRG1      T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3     Hs.495985        chr11q13.2            283          0
  212203_x\_at      IFITM3                   interferon induced transmembrane protein 3 (1--8 U)                 Hs.374650        chr11p15.5            279          0
  242705_x\_at     Hs.592928                        Full length insert cDNA clone YT86E01                        Hs.592928                              277          0
  204351_at          S100P                             S100 calcium binding protein P                             Hs.2962          chr4p16              262          0
  201650_at          KRT19                                       keratin 19                                                       chr17q21.2            260          0
  229125_at         ANKRD38                               ankyrin repeat domain 38                               Hs.283398        chr1p31.3             238          0
  224646_x\_at        H19                   H19, imprinted maternally expressed untranslated mRNA                Hs.533566        chr11p15.5            208          0
  221538_s\_at      PLXNA1                                        plexin A1                                      Hs.432329        chr3q21.3             204          0
  210381_s\_at       CCKBR                               cholecystokinin B receptor                               Hs.203          chr11p15.4            196          0
  217853_at          TNS3                                         tensin 3                                       Hs.520814        chr7p12.3             194          0
  209771_x\_at       CD24                                       CD24 molecule                                    Hs.644105         chr6q21              194          0
  210201_x\_at       BIN1                                   bridging integrator 1                                Hs.193163         chr2q14              156          0
  224579_at        Hs.592612                         solute carrier family 38, member 1                          Hs.533770       chr12q13.11            147          0
  204720_s\_at      DNAJC6                       DnaJ (Hsp40) homolog, subfamily C, member 6                     Hs.647643      chr1pter-q31.3          135          0
  212444_at        Hs.632997                              CDNA clone IMAGE:6025865                               Hs.632997                              135          0
  203767_s\_at        STS                steroid sulfatase (microsomal), arylsulfatase C, isozyme S              Hs.522578        chrXp22.32            135          0
  215729_s\_at       VGLL1                              vestigial like 1 (Drosophila)                            Hs.496843        chrXq26.3             134          0
  227241_at          MUC15                            mucin 15, cell surface associated                          Hs.407152        chr11p14.3            133          0
  204121_at         GADD45G                     growth arrest and DNA-damage-inducible, gamma                     Hs.9701      chr9q22.1-q22.2          125          0
  212077_at          CALD1                                       caldesmon 1                                     Hs.490203         chr7q33              122          0
  201787_at          FBLN1                                        fibulin 1                                      Hs.24601        chr22q13.31            121          0
  202286_s\_at      TACSTD2                     tumor-associated calcium signal transducer 2                     Hs.23582        chr1p32-p31            109          0
  218571_s\_at      CHMP4A                             chromatin modifying protein 4A                            Hs.279761         chr14q12             108          0
  205829_at         HSD17B1                       hydroxysteroid (17-beta) dehydrogenase 1                       Hs.50727        chr17q11-q21           108          0
  205093_at         PLEKHA6               pleckstrin homology domain containing, family A member 6               Hs.253146        chr1q32.1             105          0
  209735_at          ABCG2                  ATP-binding cassette, sub-family G (WHITE), member 2                 Hs.480218         chr4q22              104          0
  213050_at          COBL                                cordon-bleu homolog (mouse)                             Hs.99141         chr7p12.1             97           0
  205081_at          CRIP1                          cysteine-rich protein 1 (intestinal)                         Hs.122006       chr14q32.33            93           0
  209262_s\_at       NR2F6                     nuclear receptor subfamily 2, group F, member 6                   Hs.466148        chr19p13.1            91           0
  203438_at          STC2                                      stanniocalcin 2                                   Hs.233160        chr5q35.2             90           0
  214285_at          FABP3                     fatty acid binding protein 3, muscle and heart                    Hs.584756       chr1p33-p32            89           0
  209369_at          ANXA3                                       annexin A3                                      Hs.480042       chr4q13-q22            89           0
  209723_at        SERPINB9               serpin peptidase inhibitor, clade B (ovalbumin), member 9              Hs.104879         chr6p25              88           0
  209921_at         SLC7A11    solute carrier family 7, (cationic amino acid transporter, y+ system) member 11   Hs.390594       chr4q28-q32            87           0
  216604_s\_at      SLC7A8     solute carrier family 7 (cationic amino acid transporter, y+ system), member 8    Hs.632348        chr14q11.2            86           0
  228949_at         GPR177                             G protein-coupled receptor 177                            Hs.647659        chr1p31.3             84           0
  202007_at          NID1                                         nidogen 1                                      Hs.356624         chr1q43              84           0
  209513_s\_at       HSDL2                           hydroxysteroid dehydrogenase like 2                         Hs.59486          chr9q32              83           0
  225520_at         MTHFD1L           methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like           Hs.591343        chr6q25.1             82           0
  202023_at          EFNA1                                        ephrin-A1                                      Hs.516664       chr1q21-q22            81           0
  205710_at          LRP2                         low density lipoprotein-related protein 2                      Hs.470538       chr2q24-q31            78           0
  217764_s\_at       RAB31                            RAB31, member RAS oncogene family                          Hs.99528         chr18p11.3            77           0
  225516_at         SLC7A2     solute carrier family 7 (cationic amino acid transporter, y+ system), member 2    Hs.448520      chr8p22-p21.3           77           0
  200832_s\_at        SCD                       stearoyl-CoA desaturase (delta-9-desaturase)                     Hs.558396       chr10q23-q24           76           0
  202418_at          YIF1A                    Yip1 interacting factor homolog A (S. cerevisiae)                  Hs.446445         chr11q13             74           0
  200872_at         S100A10                           S100 calcium binding protein A10                           Hs.143873         chr1q21              74           0
  209603_at          GATA3                                 GATA binding protein 3                                Hs.524134         chr10p15             73           0
  1555832_s\_at      KLF6                                   Kruppel-like factor 6                                 Hs.4055          chr10p15             73           0
  202737_s\_at       LSM4               LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae)            Hs.515255       chr19p13.11            71           0
  226604_at          TMTC3                 transmembrane and tetratricopeptide repeat containing 3               Hs.331268       chr12q21.32            71           0
  220139_at         DNMT3L                       DNA (cytosine-5-)-methyltransferase 3-like                      Hs.592165        chr21q22.3            70           0
  206269_at          GCM1                        glial cells missing homolog 1 (Drosophila)                      Hs.28346        chr6p21-p12            69           0
  203743_s\_at        TDG                                  thymine-DNA glycosylase                               Hs.584809        chr12q24.1            69           0
  219010_at        C1orf106                          chromosome 1 open reading frame 106                         Hs.518997        chr1q32.1             69           0
  225021_at         ZNF532                                 zinc finger protein 532                               Hs.529023       chr18q21.32            69           0
  205524_s\_at      HAPLN1                       hyaluronan and proteoglycan link protein 1                      Hs.591758        chr5q14.3             68           0
  206548_at        FLJ23556                             hypothetical protein FLJ23556                                            chr10q26.11            66           0
  202800_at         SLC1A3      solute carrier family 1 (glial high affinity glutamate transporter), member 3    Hs.481918         chr5p13              65           0
  229699_at        Hs.61558                         CDNA FLJ45384 fis, clone BRHIP3021987                        Hs.61558                               65           0
  229830_at        Hs.376032                                  Transcribed locus                                  Hs.535898                              65           0
  202308_at         SREBF1                sterol regulatory element binding transcription factor 1               Hs.592123        chr17p11.2            64           0
  203219_s\_at       APRT                             adenine phosphoribosyltransferase                          Hs.28914          chr16q24             64           0
  225078_at          EMP2                               epithelial membrane protein 2                            Hs.531561        chr16p13.2            64           0
  218180_s\_at      EPS8L2                                       EPS8-like 2                                     Hs.55016         chr11p15.5            63           0
  201440_at          DDX23                        DEAD (Asp-Glu-Ala-Asp) box polypeptide 23                      Hs.130098       chr12q13.12            62           0
  201236_s\_at       BTG2                                   BTG family, member 2                                 Hs.519162         chr1q32              62           0
  218721_s\_at      C1orf27                          chromosome 1 open reading frame 27                          Hs.371210         chr1q25              61           0
  223062_s\_at       PSAT1                            phosphoserine aminotransferase 1                           Hs.494261        chr9q21.2             61           0
  201613_s\_at       AP1G2                   adaptor-related protein complex 1, gamma 2 subunit                  Hs.343244        chr14q11.2            60           0
  211986_at          AHNAK                            AHNAK nucleoprotein (desmoyokin)                           Hs.502756        chr11q12.2            60           0
  223449_at         SEMA6A     sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A   Hs.156967        chr5q23.1             60           0
  1567107_s\_at      TPM3                                       tropomyosin 4                                    Hs.631618        chr19p13.1            58           0
  208659_at          CLIC1                            chloride intracellular channel 1                           Hs.414565     chr6p22.1-p21.2          57           0
  202546_at          VAMP8                   vesicle-associated membrane protein 8 (endobrevin)                  Hs.534373      chr2p12-p11.2           57           0
  227042_at        LOC150223                           hypothetical protein LOC150223                            Hs.355952       chr22q11.21            57           0
  202625_at           LYN                 v-yes-1 Yamaguchi sarcoma viral related oncogene homolog               Hs.651186         chr8q13              56           0
  235436_at        BE503800                                                                                                                             55           0
  223839_s\_at     Hs.597496                                       PRO1933                                       Hs.597496                              55           0
  202830_s\_at      SLC37A4         solute carrier family 37 (glycerol-6-phosphate transporter), member 4        Hs.132760        chr11q23.3            54           0
  228834_at          TOB1                                  transducer of ERBB2, 1                                Hs.649528         chr17q21             54           0
  210589_s\_at        GBA                   glucosidase, beta; acid (includes glucosylceramidase)                Hs.282997         chr1q21              53           0
  208683_at          CAPN2                             calpain 2, (m/II) large subunit                           Hs.350899       chr1q41-q42            53           0
  201428_at          CLDN4                                        claudin 4                                      Hs.647036        chr7q11.23            52           0
  217775_s\_at       RDH11                    retinol dehydrogenase 11 (all-trans/9-cis/11-cis)                  Hs.226007        chr14q24.1            51           0
  208613_s\_at       FLNB                        filamin B, beta (actin binding protein 278)                     Hs.476448        chr3p14.3             49           0
  230204_at        AU144114                                                                                                                             49           0
  209710_at          GATA2                                 GATA binding protein 2                                Hs.367725        chr3q21.3             48           0
  215464_s\_at      TAX1BP3              Tax1 (human T-cell leukemia virus type I) binding protein 3             Hs.12956          chr17p13             47           0
  1559266_s\_at    FLJ45187                            hypothetical protein LOC387640                            Hs.350848       chr10p12.31            47           0
  202090_s\_at       UQCR                     ubiquinol-cytochrome c reductase, 6.4 kDa subunit                  Hs.534521        chr19p13.3            47           0
  209652_s\_at        PGF        placental growth factor, vascular endothelial growth factor-related protein     Hs.252820       chr14q24-q31           47           0
  232164_s\_at       EPPK1                                       epiplakin 1                                     Hs.200412        chr8q24.3             47           0

Expression of Genes Encoding Proteins which Play a Role in Apoptosis in Day 3 Embryos and TE Samples {#s2c}
----------------------------------------------------------------------------------------------------

We then investigated the expression of genes coding for proteins linked to the extrinsic and intrinsic apoptosis pathways in day 3 embryos and TE cells. The expression of genes of the *TNF* ligand and receptor family was not different in day 3 embryos and TE cells. Conversely, several genes belonging to the *BCL-2*, *BIRC* and *Caspase* families appeared to be differentially expressed in the two groups ([Figure 4A](#pone-0039306-g004){ref-type="fig"}). Specifically, the *BCL-2* family members *BCL2L10* (×37, FDR \<0.0001), *BCL2L11* (×16, FDR \<0.001), and *BIK* (×3.7, FDR \<0.001*)*, the expression of which was validated by qRT-PCR ([Figure 3](#pone-0039306-g003){ref-type="fig"}), and the *BIRC* family member *BIRC2* (×4, FDR \<0.001) were up-regulated in day 3 embryos. *Caspase 6* (×3, FDR \<0.001) was over-expressed in TE cells. *MCL-1*, a gene that belongs to the *BCL2* family and promotes cell survival, was strongly expressed in both day 3 embryos and TE samples.

![Differential expression of apoptosis and stemness-related genes in day 3 embryos and TE samples.\
(A) Histograms show the microarray signal values for apoptosis-related genes in day 3 embryos (black) and TE samples (white). (B) The mean expression level of 48 stemness genes in six day 3 embryos and five TE samples was plotted on a logarithmic scale in a radar graph. Asterisks indicate a statistically significant difference (*P*\<0.05) between TE and day 3 embryos (Mann-Whitney test).](pone.0039306.g004){#pone-0039306-g004}

Evaluation of DNA Repair Regulation in Day 3 Embryos and TE Samples {#s2d}
-------------------------------------------------------------------

The microarrays data were also used to investigate the expression of a comprehensive list of DNA repair genes [@pone.0039306-Wood1] in day 3 embryos and TE samples ([Tables S1](#pone.0039306.s006){ref-type="supplementary-material"} and [S2](#pone.0039306.s007){ref-type="supplementary-material"}). Of the 123 DNA damage repair genes investigated, five \[*UNG*, *RFC1*, *UNG2* (now named *CCNO*), *PCNA*, *MSH2*\] were up-regulated in day 3 embryos and eleven \[*BRCA1*, *TDG*, *FANCG*, *FEN1*, *XRCC5*, *XRCC6*, *XPC*, *MUTYH*, *XPA*, *SMUG1*, *POLD2*\] in TE cells. We then analyzed the functional relationship between the DNA damage repair genes that were differentially expressed in TE samples and day 3 embryos using the Ingenuity Pathway Analysis (IPA) software. In both cases, all the DNA repair genes displayed a documented functional interaction with each other, forming a tightly connected network ([Figure S3](#pone.0039306.s003){ref-type="supplementary-material"}).

Stemness Genes and Transcriptional Regulatory Networks Identified in Day 3 Embryos and TE Cells {#s2e}
-----------------------------------------------------------------------------------------------

We then performed a stemness gene enrichment analysis using a previously published dataset from hESCs, in which we defined a consensus hESC stemness gene list (n = 48 genes) [@pone.0039306-Assou1]. The key stemness factors *NANOG*, *POU5F1* (*OCT3/4*) and *SOX2* [@pone.0039306-Boyer1] were enriched in day 3 human embryos, whereas *DNMT3B*, *LIN28*, *PHF17*, *SEPHS1* were over-represented in TE cells. Conversely, other genes, such as *UGP2* and *PIM2,* were enriched in both day 3 embryos and TE samples ([Figure 4B](#pone-0039306-g004){ref-type="fig"}). Bioinformatic gene pathway analysis (Ingenuity software) of the day 3 embryo molecular signature showed that many genes of the *NANOG* signaling pathway, including *NANOG* ([Figure 5](#pone-0039306-g005){ref-type="fig"}), were up-regulated in day 3 human embryos, thus confirming the role of *NANOG* in the maintenance of pluripotency [@pone.0039306-Darr1]. The "TE molecular signature" included transcription factors such as *GCM1*, which is induced by Transforming Growth Factor-β (*TGF-β*) [@pone.0039306-Wu1], and Bone Morphogenic Protein 4 (*BMP4*) that induces the differentiation of pluripotent stem cells to trophoblast cells [@pone.0039306-Bai1], [@pone.0039306-Xu1]. Other components of the *TGF-β* signaling cascade, such as Transforming Growth Factor Beta Receptor III (*TGFBRIII*), were also included in the "TE molecular signature".

![Up-regulated genes that are related to the *NANOG* pathway, or to metabolic and epigenetic functions in day 3 human embryos and TE samples.\
(A) The interaction network was generated with the Ingenuity software and shows that many genes from the *NANOG* pathway are up-regulated (red) in day 3 embryos. (B) Top-ranked functional networks in which are involved transcription factors (*GATA2* and *GATA3*), or genes that regulate steroidogenesis (including *HSD1B3*), DNA repair (*TDG* and *BRCA1*) or epigenetic modifications (including *DNMT3L)* and that are up-regulated in TE samples. The color intensity indicates their degree of up-regulation. Uncolored genes were identified as not differentially expressed by our analysis, but were, nevertheless, integrated into the computationally generated networks on the basis of the evidence stored in the IPA knowledge memory indicating a relevance to this network. In each network, nodes indicate genes, a plain line indicates direct interaction, a dashed line indicates indirect interaction; a line without arrowhead indicates binding only; a line with an arrowhead indicates "acts on".](pone.0039306.g005){#pone-0039306-g005}

Dynamic Expression of Epigenetic and Metabolic Regulators During Trophoblast Development {#s2f}
----------------------------------------------------------------------------------------

Since specification of the TE lineage during blastocyst formation involves initiation of differentiation, it is likely that epigenetic regulators may have an important role in this first developmental decision. The majority of the epigenetic regulators that were up-regulated in TE cells are associated with a repressive epigenetic status ([Figure 5](#pone-0039306-g005){ref-type="fig"}). Specifically, the expression of the DNA methyl transferases (DNMT) *DNMT3A*, *DNMT3B* and *DNMT1* increased between 2- and 13-fold in TE cells in comparison to day 3 embryos. *DNMT3L* expression was 70-fold higher in TE samples than in day 3 embryos. Similarly, several transcripts coding for proteins involved in chromatin remodeling and histone modification (*SMARCA4*, *SMARCC1* and *SMARCE1*) were up-regulated between 2- and 7-fold in TE cells. Conversely, many histone deacetylases (*HDAC9*and *HDAC2*) and histone acetyltransferases (*HAT1*, *SETD8*, *RNF20*, *TAF1*, *STK17B*, *31*, *32B* and *35*) were down-regulated in TE cells in comparison to day 3 embryos. Another feature of the TE molecular signature was the up-regulation of several metabolic genes. Specifically, genes that are involved in estrogen biosynthesis (*CYP11A1* x35, *CYP19A1* x14) and lipid metabolism (*PTGES* x20) were strongly up-regulated in TE cells. One of the most striking observations was the high expression of genes that are involved in steroidogenesis (*HSD3B1* ×383, *STS* ×135, *HSD17B1* ×108, *FDX1* ×14 and *SRA1* ×6).

Intersection with the Transcriptomes of Mature MII Oocytes and hESCs {#s2g}
--------------------------------------------------------------------

In an effort to link the genes involved in the day 3 embryo-TE transition with early embryonic development, we further investigated differences and similarities in the gene expression patterns of MII oocytes, day 3 embryos, TE cells and hESCs samples (comprehensive list in [Table S4](#pone.0039306.s009){ref-type="supplementary-material"}). The genes that were found to be up-regulated in day 3 embryos ([Table S1](#pone.0039306.s006){ref-type="supplementary-material"}) and TE cells ([Table S2](#pone.0039306.s007){ref-type="supplementary-material"}) were individually compared to those up-regulated in MII oocytes and hESCs using Venn diagrams ([Figure S4](#pone.0039306.s004){ref-type="supplementary-material"}). Only 36 genes were common to both the TE and the MII oocyte signatures. On the other hand, day 3 embryos and MII oocytes shared a set of 511 genes, among which many are associated with oogenesis, such as *DAZL*, *GDF9* and *FIGLA*. Finally, 1263 genes were common to both TE and hESC profiles, whereas only 124 genes were shared by day 3 embryos and the hESCs. Genes that were up-regulated in both TE and hESC samples were associated with cell death and proliferation (*BAG6*, *CASP2* and *ANXA3*), metabolism (*GCDH* and *HPGD*) and WNT signaling (*FZD5*, *AXIN1* and *TCF3*). Genes that were up-regulated in both day 3 embryos and hESCs (124 genes) are involved in the maintenance of pluripotency and tissue development, such as *NANOG*. Among the genes specifically up-regulated in TE samples (644 genes), key genes related to epigenetic and metabolic pathways, such as *DNMT3L*, *HSD3B1* and *HSD17B1*, were observed.

Discussion {#s3}
==========

Here, we compared the transcriptomes of day 3 human embryos and TE cells from day 5 human blastocysts to identify transcripts that are differentially expressed during the embryo-to-TE transition and the specification of the TE cell lineage. Many of the genes that were up-regulated in TE cells are already known to be associated with human TE differentiation [@pone.0039306-Yagi1], [@pone.0039306-Cheng1]. For instance, we confirmed that *GATA3* and *KRT18*, two trophoblast-determining genes, are enriched in TE from human blastocysts [@pone.0039306-Adjaye1]. Moreover, the "TE molecular signature" included also unexpected genes, the TE-specificity of which has been overlooked. For instance, *CCKBR* activates signaling pathways involved in cell proliferation or migration [@pone.0039306-Daulhac1], [@pone.0039306-Todisco1] and stimulates the expression of *β*1-Integrin *in vitro* [@pone.0039306-Cayrol1]. A number of cell adhesion genes that might be implicated in the embryo attachment to the endometrium were also up-regulated in TE cells, including members of the Integrin family (*ITGB5)* and genes related to extracellular matrix remodeling, such as Laminins (*LAMA1* and *LAMC1*). In humans, active steroid hormones, including progesterone that is secreted by mouse TE cells [@pone.0039306-Peng1], are essential for implantation and maintenance of pregnancy. Our analysis reveals that *HSD3B1*, *HSD17B1* and *FDX1*, which encode enzymes involved in the metabolism of cholesterol, were specifically up-regulated in TE cells in comparison to day 3 embryos ([Figure S5](#pone.0039306.s005){ref-type="supplementary-material"}). Moreover, *PTGES* (Prostaglandin E synthase) as well as *CYP11A1* and *CYP19A1* (estrogen synthesis) were also up-regulated in TE cells, suggesting a central role of these steroidogenic enzymes in TE steroid biosynthesis and metabolism. Thus, the TE joins the group of tissues with "steroidogenic" activity, such as brain, heart, gonads, endometrium and placenta [@pone.0039306-Aghajanova1], [@pone.0039306-KayesWandover1]. It is now important to compare the steroidogenic gene expression profiles in TE cells isolated from good and bad quality blastocysts to fully correlate specific transcriptional events with efficient TE development.

Among the models used to study trophoblast development, hESCs have emerged as a useful tool to examine the emergence and differentiation of TE cells. Particularly, the transcriptomic analysis of TE cells derived from hESCs has provided new insights into the signaling pathways and the molecular mechanisms underlying early trophoblast development. Recently, by using a microarray approach, Marchand and colleagues investigated gene expression during differentiation of hESCs into the trophoblast lineage upon addition of Bone Morphogenetic Protein 4 (BMP4) for 10 days and identified 670 genes that were up-regulated from day 0 to day 10 [@pone.0039306-Marchand1]. By intersecting these genes with those we found to be up-regulated in TE cells isolated from day 5 embryos, we found 104 common genes (see [Table S5](#pone.0039306.s010){ref-type="supplementary-material"}) among which there were not only trophoblast markers (for instance, *GATA3* and *KRT19*), but also many genes implicated in lipid metabolism and estrogen biosynthesis (i.e., *CYP19A1*, *CYP11A1*, *HSD17B1*, *HSD3B1*, *PTGES*, *STS*, *HPGD*, *SLCO2A1*, *HMOX1*, *ABCG2*, *ASAH1* and *SMPD1*). This finding validates the importance of metabolic genes during TE specification. Aghajanova et al. [@pone.0039306-Aghajanova2] compared the transcriptome of embryo-derived TE cells with that of hESC-derived TE cells and found that most of the shared genes were involved in the development of receptive endometrium during implantation. Suzuki et al. [@pone.0039306-Suzuki1] used human embryonic carcinoma cells (G3), which can differentiate into TE cells, as an experimental model to investigate the molecular mechanism of trophoectoderm differentiation. Thus, comparative studies using human TE and hESC or G3 cells are relevant to better understand the molecular basis of cell fate decisions and to develop models of human TE development.

The "day 3 embryo molecular signature" was enriched in genes from the *NLRP* (named *NALP*) family which might play a role in early embryo development [@pone.0039306-Zhang2], [@pone.0039306-Hamatani2]. Indeed, *NLRP5*, *NLRP8* and *NLRP9* are expressed in bovine and human pre-implantation embryos [@pone.0039306-Zhang2], [@pone.0039306-Ponsuksili1] and, in pregnant *NLRP*5 null female mice, embryo development is arrested at the two-cell stage [@pone.0039306-Tong1]. Remarkably, many genes of the day 3 signature belong to the Melanoma Antigen family and the Ret finger protein-like family. Most of their functions remain largely unknown, but some of them are thought to regulate, respectively, placenta and early embryo development [@pone.0039306-Jungbluth1], [@pone.0039306-Suzumori1]. Mouse data suggest that two other day 3 embryo-specific genes (*MBD3L2* and *ZSCAN4)* might regulate early embryo development. In mouse embryos, *MBD3L2* expression coincides with EGA [@pone.0039306-Telford1] and *ZSCAN4* (zinc finger and SCAN domain containing 4) is important for the progression from the 2-cell to 4-cell stage [@pone.0039306-Falco1]. *ZSCAN4* plays also a key role in defying cellular senescence and maintaining a normal karyotype during propagation of embryonic stem cells in culture [@pone.0039306-Zalzman1]. Additionally, the expression levels of *DPPA5*, *DPPA2* and the stemness factor *NANOG* were much higher in day 3 embryos than in TE samples. The reciprocal pattern of expression of *Nanog* and the transcription factors *Gata6* and *Cdx2* in the mouse morula suggests that *Nanog* might determine ICM pluripotency by repressing *Gata6* and *Cdx2*, which are implicated in the extra-embryonic lineage specification [@pone.0039306-Rossant1].

Our transcriptome analysis also shows that the TE molecular signature includes many genes that are annotated as "membrane", demonstrating a strong bias towards genes involved in cell-to-cell communication processes. Conversely, genes specifically expressed by day 3 embryos are largely "nuclear". Additionally, we categorized the genes that were up-regulated during the MII-day 3 transition according to their molecular and cellular function using the GO annotations and found that they were mainly associated with nuclear localization. This is in line with previously published data showing that proteins produced by the most up-regulated genes during the MII-day 2 embryo transition are mainly localized in the nucleus [@pone.0039306-Zhang1] and that hESC-specific genes are significantly depleted in extracellular signaling components [@pone.0039306-Assou1]. One assumption that can be inferred from these findings is that the determinants of the MII-embryo transition and pluripotency may be regulated by intrinsic factors.

Apoptotic cell death has been observed in human and other mammalian pre-implantation embryos [@pone.0039306-Boumela1]. The expression profile of apoptosis-related genes in day 3 embryos suggests that the balance between anti- (*BCL2L10* and *BIRC2*) and pro-apoptotic factors (*BCL2L11* and *BIK*) might be critical at this stage of development. As the onset of EGA occurs at day 3 post-fertilization in humans, embryos that fail to accurately activate their genome might be committed to death by default. In contrast to mouse blastocysts where apoptosis occurs predominantly in ICM cells [@pone.0039306-Handyside1], apoptotic nuclei have been detected in both ICM and TE cells in human blastocysts [@pone.0039306-Hardy1]. Accordingly, we show that some molecular actors of apoptosis signaling are up-regulated in human TE cells (i.e. *Caspase 6*, *MCL-1*).

The expression of some DNA repair genes has been detected in mammalian embryos at different stages of development [@pone.0039306-Jaroudi1]. Our data show that two "DNA damage sensor" genes (*RFC1* and *PCNA1*) and two "base excision repair" genes (*UNG* and *UNG2* (now named as *CCNO*)) are up-regulated in human day 3 embryos, in line with previous works [@pone.0039306-Jaroudi2], and three "Double strand break repair" genes (*BRCA1*, *XRCC5* and *XRCC6*) are over-expressed in TE cells. In homozygous *Brca1^5--6^* mouse mutants, in which exons 5 and 6 of *Brca1* were deleted, the development of the extra-embryonic region was abnormal and diploid trophoblast cells were absent [@pone.0039306-Hakem1]. This may indicate that the "Double strand break repair" activity may be important for TE specification.

Epigenetic mechanisms, including DNA methylation, are key elements for controlling gene expression during the embryo-TE transition. In mouse blastocysts, DNA methyltransferase expression is restricted to the ICM, in which nuclei are highly methylated [@pone.0039306-Watanabe1], whereas in human and bovine blastocysts, DNA methylation is higher in TE than ICM cells [@pone.0039306-Fulka1]. Here we report a strong expression of DNA (cytosine-5) methyltransferases (*DNMT3A*, *DNMT3B*, *DNMT1* and *DNMT3L*) in human TE cells ([Figure 5](#pone-0039306-g005){ref-type="fig"}). *DNMT3A* and *DNMT3B* are de novo enzymes that establish methylation patterns. *DNMT1* is a maintenance enzyme involved in preserving already acquired methylation patterns. *DNMT3L* lacks a catalytic domain, but can interact with the de novo enzymes [@pone.0039306-Ooi1], stimulating their activity [@pone.0039306-Suetake1]. Comparison with other samples including MII oocytes and hESCs suggests that *DNMT3L* is specifically up-regulated in TE cells ([Figure S4](#pone.0039306.s004){ref-type="supplementary-material"}). However, DNA methylation levels have been described to be globally low in extra-embryonic tissues in both mouse and human embryos [@pone.0039306-KokaljVokac1], [@pone.0039306-Chapman1]. In these tissues, DNA (cytosine-5) methyltransferases enzymes are expressed only transiently and do not contribute to adult tissues maintenance, thus long-term epigenetic reprogramming may not be critical for extra-embryonic tissues. Moreover, the high expression of different epigenetic regulators in human TE cells could be a consequence of *in vitro* embryo culture. Studies in animal models have demonstrated that under certain *in vitro* culture conditions, DNA methylation profiles can be altered [@pone.0039306-Mann1]. In another hand, the association between *in vitro* culture conditions during assisted reproduction and increased risk of some epigenetic disorders has been reported, clearly indicating that epigenetic deregulation must be considered when examining in vitro fertilized embryos. Our findings suggest that epigenetic modifiers cooperate with transcription factors and DNA repair genes to regulate the whole gene expression profile in TE cells ([Figure 5](#pone-0039306-g005){ref-type="fig"}). Disruption of this epigenetic regulatory circuit might lead to alterations of the normal physiological functions. Therefore, a comprehensive elucidation of this regulatory network would be highly beneficial for understanding TE anomalies and for improving assisted reproduction procedures. Moreover, a better knowledge on the TE-specific genes and the transcriptional networks operative in TE cells and day 3 embryos might led to the identification of new biomarkers that might be used as diagnostic tools to monitor the health, viability and competence of embryos in assisted reproduction programs.

Limitations {#s3a}
-----------

As the day 3 embryos and the day 5 embryos used to isolate TE cells were donated from infertile women who underwent IVF treatments, the gene expression profiles could be have been influenced by the controlled ovarian stimulation (COS) carried out during IVF and thus they might not completely reflect the physiological situation under natural cycles. Moreover, due to the bioethics law that regulates the research on human embryos in France, the number of embryos donated for research is smaller. In view of these limitations, we optimized our technique to obtain transcriptome data for each single embryo and trophectoderm sample, respectively.

Materials and Methods {#s4}
=====================

Specimen Collection and Processing {#s4a}
----------------------------------

Human day 3 (post-fertilization) embryos and day 5 blastocysts were donated for research by infertile couples undergoing IVF treatment. All patients signed informed consent forms and the protocol for collecting human embryos and TE was approved by the Ethical Committee of the French National Agency of Biomedicine.

### Day 3 embryos {#s4a1}

9 embryos from 6 different couples were used for microarray analyses (n = 6) and qRT-PCR validation (n = 3). Day 3 embryos were all 6--8 cells with \<20% fragmentation. Each embryo was individually transferred in a tube containing extraction buffer and frozen at −80°C for subsequent RNA extraction.

### Trophectoderm biopsy {#s4a2}

8 day 5 blastocysts were used for TE isolation for microarray analyses (n = 5) and qRT--PCR validation (n = 3). Blastocysts were fully expanded with a well-defined ICM and TE was scored according to Gardner [@pone.0039306-Gardner1]. After removal of the zona pellucida, TE was mechanically dissected from ICM. All TE samples were immediately transferred in tubes containing RLT lysis buffer and frozen at −80°C.

### Mature MII oocytes and hESCs {#s4a3}

After informed consent, unfertilized MII oocytes were collected 24 or 48 hours post-insemination as previously described [@pone.0039306-Assou4]. Briefly, three pools of 16 MII oocytes (6 patients), 21 MII oocytes (8 patients) and 24 MII oocytes (8 patients) provided from couples referred to our center for conventional IVF for tubal infertility or for ICSI for male infertility were used for microarray analyses and qRT-PCR validation. The three hESC lines (HD83, HD90 and HD129) were derived by our group. Briefly, derivation of these lines was carried out using mechanical extraction of the inner cell mass [@pone.0039306-Strom1]. The culture medium used for hESC derivation and culture consisted of 80% KO-DMEM, 20% Knockout serum replacement (KO-SR), 0.1 mM non-essential amino acids, 2 mM L-Glutamine, 0.5 mM β-mercaptoethanol and 10 ng/mL of bFGF. Passaging was performed mechanically by cutting the colony using a \#15 scalpel under microscope. Mitotically inactivated (by irradiation) human foreskin fibroblasts (HFF) were used as feeder cells. HFFs were cultured in 85% DMEM, 15% FBS. HD83, HD90 and HD129 hESC lines were used for microarray analyses and HD90, HD129 and HS181 (imported from the Karolinska Institute (Stockholm, Sweden)) hESC lines were used for qRT--PCR validation.

### RNA extraction {#s4a4}

The RNeasy Micro kit (Qiagen) was used to isolate total RNA from TE samples and the Picopure RNA isolation kit (Arcturus Reagents/Molecular Devices, KIT0204, USA) for day 3 embryos, according to the manufacturers' recommended protocols. The quantity and purity of the total RNAs were determined by using a NanoDrop® ND-1000 spectrophotometer (NanoDrop ND-Thermo Fisher Scientific, Wilmington, DE, USA) and their integrity by using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, <http://www.agilent.com>).

Complementary RNA (cRNA) Preparation and Microarray Processing {#s4b}
--------------------------------------------------------------

Total day 3 embryo RNA samples (from 450 pg to 855 pg) were subjected to three rounds of linear amplification and total TE RNA samples (between 50 and 100 ng) were twice amplified to generate suitable quantity of labeled cRNA for hybridization to HG-U133 plus 2.0 GeneChip arrays (Affymetrix, Santa Clara, CA, USA) as described in [@pone.0039306-Assou3] and following the standard Affymetrix instructions. Briefly, RNA was amplified from individual human embryos using the RiboAmp® HS Kit according to manufacturer's instructions (Arcturus Bioscience). During the first strand synthesis reaction, cDNA that incorporates a T7 promoter sequence is produced. This cDNA was then used as a template for the in vitro-transcription reaction driven by the T7 promoter to synthesize antisense RNA (aRNA), which was used as input for the second round of amplification. cRNA was then transcribed into cDNA and the T7 promoter was used to drive the second round of in vitro transcription. The double-stranded cDNA was then subjected to three rounds of linear amplification. The amplified aRNA was labeled with biotin using the Turbo Labeling Kit (Arctutus) and fragmented. Finally, fifteen micrograms of each labeled sample were hybridized to the HG-U133plus2 GeneChip array (Affymetrix). The microarray data were obtained in agreement with the Minimal Information about Microarray Experiment (MIAME) recommendations [@pone.0039306-Brazma1]. All data are accessible at the US National Center for Biotechnology Information, Gene Expression Omnibus (GEO) repository <http://www.ncbi.nlm.nih.gov/geo> through the provisional accession series number GSE33025.

Data Processing and Visualization {#s4c}
---------------------------------

After image processing using the Affymetrix Microarray Suite 5.0, the cell files were analyzed using the Affymetrix Expression Console software and normalized with the MAS5 algorithm by scaling each array to a target value of 100 using the global scaling method to obtain an intensity value signal for each probe set. Gene annotation was performed using NetAffx (<http://www.affymetrix.com>; March 2009). Genes with significant differential expression profiles were identified using the two-class Significance Analysis of Microarray (SAM) algorithm (<http://www-stat.stanford.edu/~tibs/SAM/>) with the Wilcoxon test and sample label permutation (n = 300). Briefly, the algorithm assigns a score to each gene based on differences in expression between conditions relative to the standard deviation of repeated measurements. The false discovery rate (FDR) is determined using permutations of the repeated measurements to estimate the percentage of genes identified by chance. The algorithm was applied to each dataset separately using FDR\<1%. Subsequently, only the genes marked as significantly up-regulated or down-regulated were considered as differentially expressed in TE or embryos compared with the other samples. For hierarchical clustering, data were log-transformed, median-centered and processed with the CLUSTER and TREEVIEW software packages [@pone.0039306-Eisen1]. To cluster the samples according to the similarity of their gene expression patterns, we performed an unsupervised principal component analysis (PCA) with the RAGE bioinformatics platform \[<http://rage.montp.inserm.fr/>\] to project samples onto three-dimensional spaces that were further visualized to see the constellation of all samples using all the detected genes. The expression of selected genes in the panel of samples that includes germinal, stem cells and adult tissues, were retrieved through our "Amazonia!" database (<http://amazonia.montp.inserm.fr/>). The Ingenuity Pathways Analysis (IPA) system (Ingenuity Systems, Redwood City, CA, USA) was used to identify networks related to the genes that were differentially expressed in day 3 embryos and TE samples.

Gene Ontologies (GO) Classification {#s4d}
-----------------------------------

Gene Ontology (GO) annotation analysis was carried out using the Fatigo+ tool <http://babelomics.bioinfo.cipf.es> [@pone.0039306-AlShahrour1] to identify biologically relevant themes among the genes that were differentially expressed in day 3 embryos and TE cells. Briefly, Fatigo+ performs a functional enrichment analysis by comparing two lists of genes by means of the Fisher's Exact Test. Gene modules used in the test are defined in different ways that include functional criteria (GO, KEGG, Biocarta, etc.). Also user-defined gene modules can be imported and used for functional enrichment.

Validation of Microarray Data by Quantitative RT--PCR Amplification {#s4e}
-------------------------------------------------------------------

Gene expression profiles derived from microarray analyses were confirmed quantitatively by real-time qRT-PCR analysis using RNAs from three TE samples, three day 3 embryos, three MII oocytes and three hESC samples. The primer sequences are shown in [Table S3](#pone.0039306.s008){ref-type="supplementary-material"}. Briefly, cDNA was reverse transcribed following the manufacturer's instructions using 500 ng of total RNA in a 20 µl reaction that contained Superscript II (Invitrogen), oligo dT primer, dNTP mixture, MgCl2 and RNase inhibitor. Aliquots of cDNA (1/25 of the RT reaction) were diluted in 50 µl reaction volume. Q-PCR was performed using a LightCycler 480 apparatus with the LC480 SYBR Green I Master kit (Roche Diagnostics, Mannheim, Germany) containing 2 µl cDNA and 0.6 mMol primers in a total volume of 10 µl. After 10 min of activation at 95°C, cycling conditions were 10 s at 95°C, 30 s at 63°C and 1 s at 72°C for 50 cycles. Gene expression levels were normalized to *GAPDH* using the following formula 100/2^ΔΔCt^ where ΔΔCt = ΔCt unknown - ΔCt positive control. Statistical comparisons were carried out using the Student's *t* test and the SPSS software. *P* values less than or equal to 0.05 were considered significant.

Supporting Information {#s5}
======================

###### 

**Scatter plots showing the comparative distribution of transcripts in mature MII oocytes, day 3 embryos, TE and hESC samples.** Each sample was plotted against all the other samples to visualize expression variations. The blue areas highlight a greater than two-fold gene expression difference (up-regulated) between the X-axis and Y-axis samples. The orange areas indicate a greater than two-fold gene expression difference (down-regulated) between the X-axis and Y-axis samples. The yellow areas highlight a 0.5- to 2-fold gene expression difference between the X-axis and Y-axis samples. For each couple of samples, the Pearson's correlation coefficient was computed (*r*).

(TIF)

###### 

Click here for additional data file.

###### 

**Quantitative RT--PCR validation of the microarray results:** All qRT--PCR results were normalized to the expression of *GAPDH* in each sample and are the mean ± SEM of individual day 3 embryos (n = 3), TE (n = 3), pooled MII oocyte (n = 3) and hESC (n = 3) samples analyzed in duplicate. *\*P*\<0.05 was considered significant

(TIF)

###### 

Click here for additional data file.

###### 

**IPA results showing the network of DNA repair genes that are up-regulated in TE samples from day 5 human blastocysts and day 3 embryos.**

(TIF)

###### 

Click here for additional data file.

###### 

**Venn diagram representing the number of genes in each comparison and the overlaps between the three main comparison groups.** The day 3 embryo/MII oocyte/hESC signatures were defined as the intersection of the day 3 embryo signature (genes over-expressed in day3 embryos compared with TE samples; 1714 genes), the MII oocytes signature (genes over-expressed in MII oocytes compared with TE cells; 4444 genes ) and the hESC signature (genes up-regulated in hESC compared to TE samples, 5502 genes). The TE/MII oocyte/hESC signature were defined as the intersection of the TE signature (genes over-expressed in TE compared with day 3 embryos; 2196 genes), the MII oocyte signature (genes over-expressed in MII oocytes compared with day 3 embryos; 3198 genes ) and the hESC signature (genes over-expressed in hESCs compared with day 3 embryos; 8584 genes). The comparison between categories were generated by using the SAM software with a fold change ≥2 and FDR \<1%.

(TIF)

###### 

Click here for additional data file.

###### 

**Expression of selected genes, which were up-regulated either in TE cells (** ***HSD3B1*** **,** ***HSD17B1*** **,** ***FDX1*** **,** ***PTGS*** **and** ***DNMT3L*** **) or day 3 embryos (** ***NANOG*** **,** ***MBD3L2*** **,** ***ZSCAN4*** **,** ***RFPL2*** **and** ***DPPA2*** **), and of beta-Actin in the panel of samples that includes MII oocytes and hESCs using the Amazonia! gene atlas explorer (** <http://www.amazonia.transcriptome.eu> **).** Abbreviations: hESC, human embryonic stem cell; hiPS, human induced pluripotent stem cells; TE, Trophectoderm; hFF, human foreskin fibroblasts; CNS, central nervous system; DT, digestive tract; H & L, Heart and muscle; HEMATO, various hematopoietic tissues; End, Endometrium; PL, placenta.

(TIF)

###### 

Click here for additional data file.

###### 

List of the 1,714 transcripts specific to the day 3 embryo molecular signature.

(XLS)

###### 

Click here for additional data file.

###### 

List of the 2,196 transcripts specific to the TE molecular signature.

(XLS)

###### 

Click here for additional data file.

###### 

Primer pairs used for validating the array data by qRT-PCR.

(DOC)

###### 

Click here for additional data file.

###### 

List of the transcripts included in the signatures analyzed in this manuscript. (a) Day 3 embryo/MII oocyte signature, (b) Day 3 embryo/hESC signature, (c) TE/MII oocyte signature, (d) TE/hESC signature, (e) specific day 3 embryo signature and (f) specific TE signature.

(XLS)

###### 

Click here for additional data file.

###### 

List of the 104 genes that were up-regulated both in TE cells obtained by hESCs differentiation in the presence of BMP4 for 10 days (transcriptome analysis by Marchand et al, [@pone.0039306-Marchand1]) and in TE cells isolated from day 5 embryos (this study).

(XLS)

###### 

Click here for additional data file.
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